![John Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Evans
Vorstandsvorsitzender bei
BEAM THERAPEUTICS INC.
Vermögen: 38 Mio $ am 31.05.2026
Profil
Zurzeit ist John Evans Chief Executive Officer & Director bei Beam Therapeutics, Inc. und Venture Partner bei ARCH Venture Partners LLC. Herr Evans ist auch im Vorstand von Verve Therapeutics, Inc. Zuvor bekleidete er die Position des Vice President-Business Development & Operations bei Agios Pharmaceuticals, Inc. und Investor Relations Kontakt bei Infinity Pharmaceuticals, Inc. Herr Evans hat einen Abschluss an der University of Pennsylvania, einen Bachelor-Abschluss an der Yale University und einen MBA an der Wharton School der University of Pennsylvania erworben.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC. 1,12 % | 01.04.2026 | 1 150 205 ( 1,12 % ) | 38 Mio $ | 31.05.2026 |
Aktuelle Nachrichten zu John Evans
Aktive Positionen von John Evans
| Unternehmen | Position | Beginn |
|---|---|---|
| BEAM THERAPEUTICS INC. | Vorstandsvorsitzender | 01.01.2017 |
Blink Therapeutics, Inc.
 Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Vorstandsvorsitzender | - |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von John Evans
| Unternehmen | Position | Ende |
|---|---|---|
| PRIME MEDICINE, INC. | Direktor/Vorstandsmitglied | 13.09.2022 |
| VERE THER | Direktor/Vorstandsmitglied | 04.08.2022 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Private Equity Investor | 31.03.2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2017 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01.07.2006 |
Ausbildung von John Evans
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Blink Therapeutics, Inc.
Blink Therapeutics, Inc. BiotechnologyHealth Technology Develops novel platform to generate therapeutic and diagnostic monoclonal antibodies | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Orbital Therapeutics, Inc.
Orbital Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA-based medicines | Health Technology |
